0000895930-13-000036.txt : 20131122 0000895930-13-000036.hdr.sgml : 20131122 20131122160150 ACCESSION NUMBER: 0000895930-13-000036 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20131122 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20131122 DATE AS OF CHANGE: 20131122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMSURG CORP CENTRAL INDEX KEY: 0000895930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 STATE OF INCORPORATION: TN FISCAL YEAR END: 0512 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22217 FILM NUMBER: 131238261 BUSINESS ADDRESS: STREET 1: 20 BURTON HILLS BLVD. STREET 2: SUITE 500 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615-665-1283 MAIL ADDRESS: STREET 1: 20 BURTON HILLS BLVD. STREET 2: SUITE 500 CITY: NASHVILLE STATE: TN ZIP: 37215 8-K 1 amsg-8k-2013-11-22.htm FROM 8-K  

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  November 22, 2013 (November 22, 2013)

 

AMSURG CORP.

(Exact Name of Registrant as Specified in Charter)

 

Tennessee

000-22217

62-1493316

(State or Other Jurisdiction of Incorporation)

(Commission

 File Number)

(I.R.S. Employer

 Identification No.)

 

 

 

20 Burton Hills Boulevard

 

 

Nashville, Tennessee

 

37215

(Address of Principal

Executive Offices)

 

(Zip Code)

 

 

 

 

(615) 665-1283

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

        Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 7.01.      Regulation FD Disclosure

 

On November 22, 2013, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.

 

Item 9.01.      Financial Statements and Exhibits

 

(d)  99 Press release dated November 22, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

SIGNATURES

 

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

AMSURG CORP.

 

 

 

By:

/s/ Claire M. Gulmi

 

 

Claire M. Gulmi

 

 

 

 

 

Executive Vice President and

 

 

Chief Financial Officer

 

 

(Principal Financial and Duly Authorized Officer)

 

 

 

Date:   November 22, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

INDEX TO EXHIBITS

 

Exhibit

 

 

Number

 

Description

99

 

Press release dated November 22, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

 

 
 EX-99 2 amsg-8k-2013-11-22-ex99.htm EX-99  

 

 

Exhibit 99

Press Release

 

 

 

 

Contact:

Claire M. Gulmi

 

 

Executive Vice President and

 

 

Chief Financial Officer

 

 

(615) 665-1283

 

AMSURG CORP. TO PRESENT AT THE

PIPER JAFFRAY 25TH ANNUAL HEALTH CARE CONFERENCE

 

NASHVILLE, Tenn. – (Nov. 22, 2013) – AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Piper Jaffray 25th Annual Health Care Conference on Tuesday, December 3, 2013, in New York City.  In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company’s web site starting at 1:30 p.m. Eastern Time / 12:30 p.m. Central Time.  Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.

 

            The live audio webcast and replay of the presentation will be available on the Company’s website by going to www.amsurg.com and clicking on Investors.  For the live audio, please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software.  The webcast replay will be available for 30 days.

 

AmSurg Corp. acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States.  At September 30, 2013, AmSurg owned and operated 243 centers.

 

- END -